▶ 調査レポート

腎臓/腎線維症治療の世界市場 2019年版:種類別(アンジオテンシンII受容体遮断薬(ARB)、アンジオテンシン変換酵素(ACE)阻害剤、ピルフェニドン、レニン阻害剤、バソペプチダーゼ阻害剤)、用途別(民間/民間病院、公衆衛生病院、クリニック、ホームトリートメント)

• 英文タイトル:Global Kidney/Renal Fibrosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

GlobalInfoResearchが調査・発行した産業分析レポートです。腎臓/腎線維症治療の世界市場 2019年版:種類別(アンジオテンシンII受容体遮断薬(ARB)、アンジオテンシン変換酵素(ACE)阻害剤、ピルフェニドン、レニン阻害剤、バソペプチダーゼ阻害剤)、用途別(民間/民間病院、公衆衛生病院、クリニック、ホームトリートメント) / Global Kidney/Renal Fibrosis Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024 / C-GIR20G2811資料のイメージです。• レポートコード:C-GIR20G2811
• 出版社/出版日:GlobalInfoResearch / 2019年12月30日
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥382,800 (USD3,480)▷ お問い合わせ
  Multi User¥574,200 (USD5,220)▷ お問い合わせ
  Corporate User¥765,600 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
「腎臓/腎線維症治療の世界市場2019年」は、グローバルにおける腎臓/腎線維症治療市場を展望するレポートです。腎臓/腎線維症治療のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測(2019年-2024年)、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどを掲載しています。
・腎臓/腎線維症治療の市場概観
・腎臓/腎線維症治療の企業概要(事業概要、製品種類、販売量、価格、売上、市場シェア等)
・腎臓/腎線維症治療の企業別販売動向、市場シェア、市場集中度、競争動向
・腎臓/腎線維症治療の世界市場規模
・腎臓/腎線維症治療の北米市場分析(アメリカ、カナダ、メキシコ等)
・腎臓/腎線維症治療のアメリカ市場規模推移
・腎臓/腎線維症治療のカナダ市場規模推移
・腎臓/腎線維症治療のメキシコ市場規模推移
・腎臓/腎線維症治療のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・腎臓/腎線維症治療のドイツ市場規模推移
・腎臓/腎線維症治療のイギリス市場規模推移
・腎臓/腎線維症治療のロシア市場規模推移
・腎臓/腎線維症治療のアジア太平洋市場分析(日本、中国、韓国、インド、東南アジア等)
・腎臓/腎線維症治療の日本市場規模推移
・腎臓/腎線維症治療の中国市場規模推移
・腎臓/腎線維症治療の韓国市場規模推移
・腎臓/腎線維症治療のインド市場規模推移
・腎臓/腎線維症治療の東南アジア市場規模推移
・腎臓/腎線維症治療の南米市場分析(ブラジル、アルゼンチン等)
・腎臓/腎線維症治療の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・腎臓/腎線維症治療の種類別分析/販売量、売上、市場シェア(アンジオテンシンII受容体遮断薬(ARB)、アンジオテンシン変換酵素(ACE)阻害剤、ピルフェニドン、レニン阻害剤、バソペプチダーゼ阻害剤)
・腎臓/腎線維症治療の用途別分析/市場規模(民間/民間病院、公衆衛生病院、クリニック、ホームトリートメント)
・腎臓/腎線維症治療の市場予測2019年-2024年(地域別予測、種類別予測、用途別予測)
・腎臓/腎線維症治療の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Kidney/Renal Fibrosis Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Kidney/Renal Fibrosis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Kidney/Renal Fibrosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Kidney/Renal Fibrosis Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers
La Jolla Pharmaceutical Company
Genzyme Corporation
Pfizer Inc.
Merck & Co.
Galectin Therapeutics
F. Hoffman-La Roche Ltd.
ProMetic Life-Sciences Inc.
InterMune Inc.
BioLine Rx Ltd

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Angiotensin II Receptor Blockers (ARBs)
Angiotensin Converting Enzyme (ACE) Inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors

Market Segment by Applications, can be divided into
Commercial/Private Hospitals
Public Health Hospitals
Clinics
Home Treatment

レポート目次

Table of Contents

1 Kidney/Renal Fibrosis Treatment Market Overview
1.1 Product Overview and Scope of Kidney/Renal Fibrosis Treatment
1.2 Classification of Kidney/Renal Fibrosis Treatment by Types
1.2.1 Global Kidney/Renal Fibrosis Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Types in 2018
1.2.3 Angiotensin II Receptor Blockers (ARBs)
1.2.4 Angiotensin Converting Enzyme (ACE) Inhibitors
1.2.5 Pirfenidone
1.2.6 Renin Inhibitors
1.2.7 Vasopeptidase Inhibitors
1.3 Global Kidney/Renal Fibrosis Treatment Market by Application
1.3.1 Global Kidney/Renal Fibrosis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Commercial/Private Hospitals
1.3.3 Public Health Hospitals
1.3.4 Clinics
1.3.5 Home Treatment
1.4 Global Kidney/Renal Fibrosis Treatment Market by Regions
1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Kidney/Renal Fibrosis Treatment (2014-2024)
2 Company Profiles
2.1 La Jolla Pharmaceutical Company
2.1.1 Business Overview
2.1.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Genzyme Corporation
2.2.1 Business Overview
2.2.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer Inc.
2.3.1 Business Overview
2.3.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Merck & Co.
2.4.1 Business Overview
2.4.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck & Co. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Galectin Therapeutics
2.5.1 Business Overview
2.5.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 F. Hoffman-La Roche Ltd.
2.6.1 Business Overview
2.6.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 ProMetic Life-Sciences Inc.
2.7.1 Business Overview
2.7.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 InterMune Inc.
2.8.1 Business Overview
2.8.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 BioLine Rx Ltd
2.9.1 Business Overview
2.9.2 Kidney/Renal Fibrosis Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Kidney/Renal Fibrosis Treatment Market Competition, by Players
3.1 Global Kidney/Renal Fibrosis Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Kidney/Renal Fibrosis Treatment Players Market Share
3.2.2 Top 10 Kidney/Renal Fibrosis Treatment Players Market Share
3.3 Market Competition Trend
4 Global Kidney/Renal Fibrosis Treatment Market Size by Regions
4.1 Global Kidney/Renal Fibrosis Treatment Revenue and Market Share by Regions
4.2 North America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
5 North America Kidney/Renal Fibrosis Treatment Revenue by Countries
5.1 North America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
5.2 USA Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
6 Europe Kidney/Renal Fibrosis Treatment Revenue by Countries
6.1 Europe Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
6.2 Germany Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
6.4 France Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue by Countries
7.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
7.2 China Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
7.5 India Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
8 South America Kidney/Renal Fibrosis Treatment Revenue by Countries
8.1 South America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
8.2 Brazil Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Kidney/Renal Fibrosis Treatment by Countries
9.1 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
10 Global Kidney/Renal Fibrosis Treatment Market Segment by Type
10.1 Global Kidney/Renal Fibrosis Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Kidney/Renal Fibrosis Treatment Market Forecast by Type (2019-2024)
10.3 Angiotensin II Receptor Blockers (ARBs) Revenue Growth Rate (2014-2024)
10.4 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2024)
10.5 Pirfenidone Revenue Growth Rate (2014-2024)
10.6 Renin Inhibitors Revenue Growth Rate (2014-2024)
10.7 Vasopeptidase Inhibitors Revenue Growth Rate (2014-2024)
11 Global Kidney/Renal Fibrosis Treatment Market Segment by Application
11.1 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2014-2019)
11.2 Kidney/Renal Fibrosis Treatment Market Forecast by Application (2019-2024)
11.3 Commercial/Private Hospitals Revenue Growth (2014-2019)
11.4 Public Health Hospitals Revenue Growth (2014-2019)
11.5 Clinics Revenue Growth (2014-2019)
11.6 Home Treatment Revenue Growth (2014-2019)
12 Global Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2024)
12.1 Global Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2024)
12.2 Global Kidney/Renal Fibrosis Treatment Market Forecast by Regions (2019-2024)
12.3 North America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
12.6 South America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Kidney/Renal Fibrosis Treatment Picture
Table Product Specifications of Kidney/Renal Fibrosis Treatment
Table Global Kidney/Renal Fibrosis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Types in 2018
Figure Angiotensin II Receptor Blockers (ARBs) Picture
Figure Angiotensin Converting Enzyme (ACE) Inhibitors Picture
Figure Pirfenidone Picture
Figure Renin Inhibitors Picture
Figure Vasopeptidase Inhibitors Picture
Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Application (2014-2024)
Figure Kidney/Renal Fibrosis Treatment Revenue Market Share by Applications in 2018
Figure Commercial/Private Hospitals Picture
Figure Public Health Hospitals Picture
Figure Clinics Picture
Figure Home Treatment Picture
Table Global Market Kidney/Renal Fibrosis Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors
Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Type and Applications
Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Type and Applications
Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Kidney/Renal Fibrosis Treatment Type and Applications
Table Pfizer Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Kidney/Renal Fibrosis Treatment Type and Applications
Table Merck & Co. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Galectin Therapeutics Basic Information, Manufacturing Base and Competitors
Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Type and Applications
Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table F. Hoffman-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Type and Applications
Table F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table ProMetic Life-Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Type and Applications
Table ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table InterMune Inc. Basic Information, Manufacturing Base and Competitors
Table InterMune Inc. Kidney/Renal Fibrosis Treatment Type and Applications
Table InterMune Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table BioLine Rx Ltd Basic Information, Manufacturing Base and Competitors
Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Type and Applications
Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Players (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Players in 2017
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Kidney/Renal Fibrosis Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Kidney/Renal Fibrosis Treatment Revenue Market Share in 2018
Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions in 2018
Figure North America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure South America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table North America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
Table North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018
Figure USA Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table Europe Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018
Figure Germany Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure UK Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure France Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018
Figure China Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure India Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table South America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019)
Table South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018
Figure Brazil Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Type (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Type (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Type in 2018
Table Global Kidney/Renal Fibrosis Treatment Revenue Forecast by Type (2019-2024)
Figure Global Kidney/Renal Fibrosis Treatment Market Share Forecast by Type (2019-2024)
Figure Global Angiotensin II Receptor Blockers (ARBs) Revenue Growth Rate (2014-2019)
Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Pirfenidone Revenue Growth Rate (2014-2019)
Figure Global Renin Inhibitors Revenue Growth Rate (2014-2019)
Figure Global Vasopeptidase Inhibitors Revenue Growth Rate (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue by Application (2014-2019)
Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Application in 2018
Table Global Kidney/Renal Fibrosis Treatment Revenue Forecast by Application (2019-2024)
Figure Global Kidney/Renal Fibrosis Treatment Market Share Forecast by Application (2019-2024)
Figure Global Commercial/Private Hospitals Revenue Growth Rate (2014-2019)
Figure Global Public Health Hospitals Revenue Growth Rate (2014-2019)
Figure Global Clinics Revenue Growth Rate (2014-2019)
Figure Global Home Treatment Revenue Growth Rate (2014-2019)
Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)